Cellular proliferation in pilocytic and diffuse astrocytomas

Citation
C. Giannini et al., Cellular proliferation in pilocytic and diffuse astrocytomas, J NE EXP NE, 58(1), 1999, pp. 46-53
Citations number
40
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
ISSN journal
00223069 → ACNP
Volume
58
Issue
1
Year of publication
1999
Pages
46 - 53
Database
ISI
SICI code
0022-3069(199901)58:1<46:CPIPAD>2.0.ZU;2-O
Abstract
Using quantitative image analysis, we evaluated the MIB-1 labeling index (L I) in a large population of pilocytic (n = 131) and diffuse astrocytomas (n = 140), explored its significance as a prognostic predictor of survival, a nd compared it to other commonly accepted predictors, including grade and i ts histologic determinants, atypia, mitoses, endothelial proliferation, and necrosis. Diffuse astrocytomas were graded according to the St Anne-Mayo s cheme and included 45 grade 2, 50 grade 3, and 45 grade 4 astrocytomas. In pilocytic astrocytomas, mean, median, and range of MIB-1 LIs were 1.1, 0.9, and 0-3.9%, respectively. In diffuse astrocytomas, these values were 2.3, 2, and 0-7.6% in grade 2; 6, 4.4, and 0.1-25.7% in grade 3; 9.1, 6, and 0.3 -36% in grade 4. There was a significant difference in the distribution of MIB-1 LIs between pilocytic and diffuse grade 2 astrocytomas (p < 0.001), b etween grade 2 and grade 3 (p < 0.001), and between tumors of grade 3 and 4 (p = 0.014). Among pilocytic astrocytomas there was no association between survival and MIB-1 LI or any histologic parameter. Ln diffuse astrocytomas , MLB-1 LI was significantly correlated with grade as well as with mitotic activity (<0.001) and survival. While in diffuse astrocytomas of all grades , necrosis was the strongest factor associated with survival, in tumors of grades 2 and 3 the MIB-1 LI preceded other histologic parameters and, on mu ltivariate analysis, remained the only feature predictive of survival. Grad e 3 astrocytomas with a single "solitary" mitosis had a significantly lower MIB-1 LI than did grade 3 tumors with >1 mitosis and, compared to the latt er, had a significantly longer survival (p = 0.013), one not significantly different from patients with grade 2 astrocytomas. These findings suggest t hat the cutoff point between grade 2 and 3 in the St. Anne-Mayo scheme may not be optimal and may need to be revised.